NanoGroup S.A. is launching the next phase of research with a proprietary innovative organ perfusion fluid
After announcing positive results from preliminary studies comparing kidneys perfused with NanOX 10 and NanOX 20 fluids with the current standard used in transplantation, NanoGroup S.A. has begun the next phase of research on the way to marketing its solution. The study, which kicked off on February 6, will take about six weeks. The goal […]